OS Therapies (OSTX)_个股概要_股票价格_行情走势图

2.780
+0.160+6.11%

收盘价 11/06 16:00 (美东)

5805.91万总市值-8853市盈率TTM

代码股票名称

最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业

自选模拟交易

Jaguar8

09/11 07:18

资讯

$OS Therapies (OSTX.US)$
OS治疗宣布基于可调抗体药物结合物（tADC）平台开发的卵巢癌治疗候选药物在临床前模型中取得积极疗效和安全数据，使用专有硅连接剂平台。
叶酸受体α靶向药物偶联物和六甲硅氧烷异曲松酮（FRA-H）药物在卵巢癌动物模型中进行了测试
FRA-H在Kb和IGROV-1小鼠卵巢癌模型中具有强大的疗效
FRA-H具有强大的安全性能，对比安慰剂未引起体重下降

已翻译

Jaguar8

08/29 06:53

NEWS

$OS Therapies (OSTX.US)$
OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose
OS Therapies Incorporated (NYSE:OSTX) ("OS Therapies" or "the Company"), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced that the last patient (Patient #41) enrolled in the AOST-2121 clinical trial (NCT04974008) of OST-HER2 in recurred, resected Osteosarcoma (OS) - has received its last treatment dos...